Literature DB >> 32294809

Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis.

Fabio Ciceri1, Luigi Beretta2, Anna Mara Scandroglio2, Sergio Colombo2, Giovanni Landoni3, Annalisa Ruggeri1, Jacopo Peccatori1, Armando D'Angelo4, Francesco De Cobelli2, Patrizia Rovere-Querini2, Moreno Tresoldi5, Lorenzo Dagna2, Alberto Zangrillo2.   

Abstract

We suggest the use of MicroCLOTS (microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome) as a new name for severe pulmonary coronavirus disease 2019 (COVID-19). We hypothesise that, in predisposed individuals, alveolar viral damage is followed by an inflammatory reaction and by microvascular pulmonary thrombosis. This progressive endothelial thromboinflammatory syndrome may also involve the microvascular bed of the brain and other vital organs, leading to multiple organ failure and death. Future steps in the understanding of the disease and in the identification of treatments may benefit from this definition and hypothesised sequence of events.

Entities:  

Keywords:  COVID-19

Year:  2020        PMID: 32294809

Source DB:  PubMed          Journal:  Crit Care Resusc        ISSN: 1441-2772            Impact factor:   2.159


  179 in total

1.  Neuroimaging Findings in Patients with COVID-19.

Authors:  P Nicholson; L Alshafai; T Krings
Journal:  AJNR Am J Neuroradiol       Date:  2020-06-11       Impact factor: 3.825

2.  Decreased in-hospital mortality in patients with COVID-19 pneumonia.

Authors:  Fabio Ciceri; Annalisa Ruggeri; Rosalba Lembo; Riccardo Puglisi; Giovanni Landoni; Alberto Zangrillo
Journal:  Pathog Glob Health       Date:  2020-06-25       Impact factor: 2.894

3.  Is time our ultimate ally in defying the pandemic?

Authors:  Giovanni Landoni; Davide Losi; Stefano Fresilli; Stefano Lazzari; Pasquale Nardelli; Riccardo Puglisi; Alberto Zangrillo
Journal:  Pathog Glob Health       Date:  2020-06-27       Impact factor: 2.894

Review 4.  Cutaneous Manifestations in Patients With COVID-19: Clinical Characteristics and Possible Pathophysiologic Mechanisms.

Authors:  F González González; C Cortés Correa; E Peñaranda Contreras
Journal:  Actas Dermosifiliogr       Date:  2021-01-28

5.  Von Willebrand factor.

Authors:  Pervinder Bhogal; Melanie Jensen; Dan Hart; Levansri Makalanda; George B Collins; Oliver Spooner; Ounali Jaffer
Journal:  Clin Med (Lond)       Date:  2020-11       Impact factor: 2.659

Review 6.  Thrombotic Risk and Covid-19: Review of Current Evidence for a Better Diagnostic and Therapeutic Approach.

Authors:  Raquel López-Reyes; Grace Oscullo; David Jiménez; Irene Cano; Alberto García-Ortega
Journal:  Arch Bronconeumol       Date:  2020-08-31       Impact factor: 4.872

Review 7.  Can fibrinolytic therapy be clinically useful in severe pneumonia caused by COVID-19?

Authors:  Rafael Bornstein; José Antonio Páramo
Journal:  J Thromb Thrombolysis       Date:  2020-08-12       Impact factor: 2.300

8.  COVID-19, thromboembolic risk and thromboprophylaxis: learning lessons from the bedside, awaiting evidence.

Authors:  Antonio Coppola; Maria Lombardi; Maria I Tassoni; Gaetano Carolla; Maurizio Tala; Rossella Morandini; Oriana Paoletti; Sophie Testa
Journal:  Blood Transfus       Date:  2020-05       Impact factor: 3.443

Review 9.  Prone positioning in conscious patients on medical wards: A review of the evidence and its relevance to patients with COVID-19 infection.

Authors:  Thomas Chad; Caroline Sampson
Journal:  Clin Med (Lond)       Date:  2020-06-05       Impact factor: 2.659

Review 10.  The Role of Hyperbaric Oxygen Treatment for COVID-19: A Review.

Authors:  Matteo Paganini; Gerardo Bosco; Filippo A G Perozzo; Eva Kohlscheen; Regina Sonda; Franco Bassetto; Giacomo Garetto; Enrico M Camporesi; Stephen R Thom
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.